hit counter
Boston Scientific Corporation (BSX) Stock News Sentiment & Price - Sentifly
BSX - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Boston Scientific Corporation (BSX)

USA
Medical Appliances & Equipment
NYSE
BSX Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BSX Latest news
Seeking Alpha
Neutral
Boston Scientific Corporation (BSX) CEO Mike Mahoney on Q3 2021 Results - Earnings Call Transcript
3 hours ago

Boston Scientific Corporation (BSX) CEO Mike Mahoney on Q3 2021 Results - Earnings Call Transcript

Zacks Investment Research
Positive
Boston Scientific (BSX) Q3 Earnings Top Estimates, Margins Up
3 hours ago

Barring CRM, Boston Scientific's (BSX) organic revenues at each of its core business segments and geographies increase in Q3.

Benzinga
Positive
Boston Scientific Q3 Earnings Comes Inline With Wall Street Expectations
6 hours ago

Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.93 billion in Q3 of 2021, almost in line with the Wall Street estimate of $2.97 billion. Sales increased 10.3% Y/Y on a reported basis and 10.6% on an organic basis, lower than the Company's guidance of 12% - 14%.

Zacks Investment Research
Positive
Boston Scientific (BSX) Q3 Earnings Beat Estimates
6 hours ago

Boston Scientific (BSX) delivered earnings and revenue surprises of 2.50% and -1.61%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Benzinga
Positive
Recap: Boston Scientific Q3 Earnings
8 hours ago

Boston Scientific (NYSE:BSX) reported its Q3 earnings results on Wednesday, October 27, 2021 at 06:30 AM. Here's what investors need to know about the announcement.

Market Watch
Positive
Boston Scientific stock gains after profit tops expectations, while sales came up a bit short
8 hours ago

Shares of Boston Scientific Corp. BSX, -0.38% rose 0.4% in premarket trading Wednesday, after the medical device company reported third-quarter profit that topped expectations, but sales that came up a bit shy, while nudging up its earnings outlook and cutting its sales growth view. The company swung to net income of $405 million, or 28 cents a share, from a loss of $169 million, or 12 cents a share, in the year-ago period.

PRNewsWire
Neutral
Boston Scientific Announces Results For Third Quarter 2021
9 hours ago

MARLBOROUGH, Mass., Oct. 27, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.932 billion during the third quarter of 2021, growing 10.3 percent on a reported basis, 9.7 percent on an operational1 basis and 10.6 percent on an organic2 basis, all compared to the prior year period.

Zacks Investment Research
Neutral
Medical Products Stock Q3 Earnings on Oct 27: TMO, EW & More
2021-10-26 11:50

With the pandemic raging on, testing, vaccine and therapeutic makers witness huge market adoption of their COVID-related support products in Q3.

Forbes
Positive
What To Expect From Boston Scientific Stock In Q3?
2021-10-25 06:00

Boston Scientific is scheduled to report its Q3 2021 results on Wednesday, Oct 27. We expect the company to report revenues and earnings in-line with the consensus estimates, driven by a rebound in volume of procedures performed.

Zacks Investment Research
Positive
Boston Scientific (BSX) Product Launches to Drive Q3 Earnings
2021-10-21 17:27

Within Urology/ Pelvic Health, Boston Scientific (BSX) is expected to have registered strong sales growth in Stone, Prostate Health and Pelvic Health franchises.

Loading more news...